Back to top
more

IceCure Medical (ICCM)

(Delayed Data from NSDQ)

$0.89 USD

0.89
381,125

-0.01 (-1.10%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $0.88 -0.01 (-1.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth A Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (98 out of 246)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Ascend Wellness Holdings, Inc. (AAWH) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Ascend Wellness Holdings, Inc. (AAWH) delivered earnings and revenue surprises of -80% and 1.70%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Revvity (RVTY) delivered earnings and revenue surprises of 4.26% and 0.45%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

IceCure Medical (ICCM) Submits Final Cryoablation Data to FDA

by Zacks Equity Research

IceCure Medical (ICCM) submits final ICE data along with multiple sub-analysis to the FDA seeking approval for marketing authorization for treating early-stage breast cancer.

Zacks Equity Research

IceCure Medical Ltd. (ICCM) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

IceCure Medical Ltd. (ICCM) delivered earnings and revenue surprises of 0% and 65.58%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

Co-Diagnostics, Inc. (CODX) delivered earnings and revenue surprises of -29.17% and 73.60%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Nutex Health Inc. (NUTX) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

Nutex Health Inc. (NUTX) delivered earnings and revenue surprises of 0% and 5.34%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

IceCure Medical Ltd. (ICCM) delivered earnings and revenue surprises of 11.11% and 25.26%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

LumiraDx Limited (LMDX) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

LumiraDx Limited (LMDX) delivered earnings and revenue surprises of 6.67% and 17.57%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

MDxHealth SA Sponsored ADR (MDXH) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

MDxHealth SA Sponsored ADR (MDXH) delivered earnings and revenue surprises of 87.50% and 6.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

Co-Diagnostics, Inc. (CODX) delivered earnings and revenue surprises of 13.04% and 45.27%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

The Beauty Health Company (SKIN) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

The Beauty Health Company (SKIN) delivered earnings and revenue surprises of -100% and 3.90%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Apollo Medical Holdings, Inc. (AMEH) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Apollo Medical Holdings, Inc. (AMEH) delivered earnings and revenue surprises of 20% and 1.70%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Andrew Rocco headshot

1,000% Move in a Day: Medical Stock Soars on Positive Data

by Andrew Rocco

IceCure Medical, a little-known medical device company surged in after-hours trading Monday. IceCure's Prosense technology proved to be a safe and effective treatment for cancerous kidney tumors.